Boston, Mass., USA and London, UK, November 08, 2018 / B3C newswire / -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biotech company dedicated to transforming
J.P. Morgan, Goldman Sachs & Co. LLC and Cowen are acting as joint book-running managers for the offering, and Wedbush PacGrow is acting as co-manager...